2-{[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl](methyl)amino}-N-[(2,4-difluorophenyl)methyl]-4-hydroxybutanamide

ID: ALA4793317

PubChem CID: 162670649

Max Phase: Preclinical

Molecular Formula: C26H30F2N2O2S2

Molecular Weight: 504.67

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccsc1C(=CCCN(C)C(CCO)C(=O)NCc1ccc(F)cc1F)c1sccc1C

Standard InChI:  InChI=1S/C26H30F2N2O2S2/c1-17-9-13-33-24(17)21(25-18(2)10-14-34-25)5-4-11-30(3)23(8-12-31)26(32)29-16-19-6-7-20(27)15-22(19)28/h5-7,9-10,13-15,23,31H,4,8,11-12,16H2,1-3H3,(H,29,32)

Standard InChI Key:  AKYJVGAZYRRULZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 36  0  0  0  0  0  0  0  0999 V2000
    3.2250   -3.0959    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.0500   -3.0959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3068   -2.3118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6375   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9725   -2.3118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5342   -3.7639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3548   -3.6787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1977   -4.5172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3917   -4.6834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3045   -5.5038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0579   -5.8403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6105   -5.2278    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.0918   -2.0579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7807   -4.1291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8389   -4.3467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6595   -4.2614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1436   -4.9294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9643   -4.8441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8072   -5.6827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4484   -5.5121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3007   -4.0908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1213   -4.0056    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8165   -3.4228    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1120   -6.2654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5961   -6.9334    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4577   -3.2522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2783   -3.1669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7615   -3.8367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5814   -3.7519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9186   -2.9979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4297   -2.3280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6116   -2.4162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7390   -2.9115    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.4241   -4.5895    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  2  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  1  0
  3 13  1  0
  9 14  1  0
  7 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 18 20  1  0
 18 21  1  0
 21 22  1  0
 21 23  2  0
 20 24  1  0
 24 25  1  0
 22 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 30 33  1  0
 28 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4793317

    ---

Associated Targets(non-human)

Slc6a11 GABA transporter 4 (930 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a13 GABA transporter 3 (681 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a1 GABA transporter 1 (1980 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 504.67Molecular Weight (Monoisotopic): 504.1717AlogP: 5.53#Rotatable Bonds: 11
Polar Surface Area: 52.57Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.56CX Basic pKa: 8.03CX LogP: 5.59CX LogD: 4.86
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.36Np Likeness Score: -0.89

References

1. Zaręba P,Gryzło B,Malawska K,Sałat K,Höfner GC,Nowaczyk A,Fijałkowski Ł,Rapacz A,Podkowa A,Furgała A,Żmudzki P,Wanner KT,Malawska B,Kulig K.  (2020)  Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice.,  188  [PMID:31901745] [10.1016/j.ejmech.2019.111920]

Source